Pediatric glycogen storage disease type V
Glycogen storage disease (GSD) is a type of glycogen metabolism disorder caused by congenital enzyme defects, which is autosomal recessive. The deficiency of muscle phosphorylase leads to the obstruction of glycogen decomposition in muscle cells and insufficient ATP production. The affected tissue is striated muscle, and the main clinical features are pain, cramps and weakness after intense muscle contraction. It is also called McArdle syndrome, McArdle-Schmid-Pearson syndrome, Cori type V glycogen storage disease, glycogen metabolism disease muscle type, muscle phosphorylase deficiency, etc.
-
Site of disease:
whole body -
Infectious :
Not contagious -
Frequent population:
child -
Related symptoms:
Muscle atrophy Liver enlargement Muscle weakness Fatigue Myalgia -
Concurrent disease:
Related Drugs
fructose
Indication: It is used to supply energy and replenish body fluids for patients with diabetes and liver disease. It can be used as an auxiliary treatment for acute ethanol poisoning.
Manufacturer:
Xiwang Pharmaceutical Co., Ltd.
fructose
Indication: It is used to supply energy and replenish body fluids for patients with diabetes and liver disease. It can be used as an auxiliary treatment for acute ethanol poisoning.
Manufacturer:
Shijiazhuang Huaxu Pharmaceutical Co., Ltd.
Related Ingredients